Actively Recruiting
Sphenopalatine Ganglion Block in Bimaxillary Orthognathic Surgery
Led by Bezmialem Vakif University · Updated on 2025-04-18
50
Participants Needed
1
Research Sites
46 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate whether sphenopalatine ganglion (SPG) block helps with intraoperative pain control, reduces postoperative edema, and decreases pain in adults aged 18 to 45 undergoing bimaxillary orthognathic surgery. The main questions it aims to answer are: * Does SPG block help decrease postoperative swelling and pain compared to a sham block? * Does it improve pain control during surgery and reduce opioid use? Researchers will compare patients receiving SPG block to those receiving a sham block to determine if this technique provides better pain relief and reduces postoperative complications. Participants will: * Be 18 to 45 years old and undergo bimaxillary orthognathic surgery. * Be randomly assigned to receive either a SPG block or a sham block before surgery. * Be monitored for 1 month after surgery to assess pain levels, swelling, opioid use, and possible complications.
CONDITIONS
Official Title
Sphenopalatine Ganglion Block in Bimaxillary Orthognathic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with bimaxillary orthognathic surgery indication
- Patients with American Society of Anesthesiologist scores (ASA) I-II
- Patients between the ages of 18-45
You will not qualify if you...
- Patients with local anesthetic allergy
- Patients undergoing genioplasty
- Syndromes associated with secondary deformities in addition to jaw deformities
- Patients with a history of jaw surgery
- Patients with uncontrolled hypertension
- Patients with a history of substance abuse
- Patients with chronic pain lasting more than 3 months
- Patients using analgesic and hypnotic agents for more than 2 weeks
- Recent situations that may cause facial edema (tooth extraction, facial trauma, etc.)
- Patients with psychiatric disorders
- Patients with diabetes mellitus
- Patients with bleeding disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bezmialem Vakıf Üniversitesi
Istanbul, Fatih, Turkey (Türkiye), 34093
Actively Recruiting
Research Team
B
Büşra Ceylan, Resident Doctor
CONTACT
H
Harun Uysal, Associate Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here